RealityLicks
Posts: 1615
Joined: 10/23/2007 Status: offline
|
Level, you are labouring under a serious misapprehension if you believe the White House line on aid in Africa. Its not uncommon for Western leaders to make these valedictory tours during their dog days in office. Sadly for the poor countries, the legend of Western benificence is not born out by the facts. quote:
The Bush Administration has significantly increased aid to Africa, but that increase falls far short of what the President has claimed. U.S. aid to Africa from FY 2000 (the last full budget year of the Clinton Administration) to FY2004 (the last completed fiscal year of the Bush Administration) has not "tripled" or even doubled. Rather, in real dollars, it has increased 56% (or 67% in nominal dollar terms). The majority of that increase consists of emergency food aid, rather than assistance for sustainable development of the sort Africa needs to achieve lasting poverty reduction. http://www.brookings.edu/articles/2005/0627africa_rice.aspx The US has never honoured its undertaking to donate 0.7% of GDP in development aid as per the OECD Monterrey Consensus. PEPFAR is nothing more than a cynical attempt to hijack the provision of low-cost generic anti-retrovirals by developing countries to developing countries. quote:
But they also charged that Bush appears determined to protect Big Pharma from competition by the generic manufacturers and they pointed to announcements shortly after Thompson's by major U.S. and western drug companies that they intended to introduce FDCs as well as evidence that the administration is doing the companies' bidding. Three big U.S. pharmaceutical companies - Bristol-Myers Squibb Co., Gilead Sciences Inc. and Merck & Co, Inc. - announced Sunday night that they are jointly pursuing development of their own one-dose-a-day anti-AIDS drug, while British-based GlaxoSmithKline and Germany's Boehringer Ingelheim Corp. said they were also considering a co-packaging deal for FSCs. Activists said they believe the administration stalled the PEPFAR program so the brand-name pharmaceutical companies could play "catch up" to the generic manufacturers in developing their own FDCs. "The U.S., while appearing to finally find religion on this issue," said Health Global Access Project's (HealthGAP) Asia Russell, "continues to buy time to lock in countries and recipients into using only patented drugs. This decision will cost money, time, and lives," she added. "The U.S. pharmaceutical industry is behind the game on FDCS, and the White House is stepping in to help them catch up with the more innovative generic producers who have pioneered FDCS," said Bill Fletcher, Jr., president of TransAfrica Forum in Washington. He and Booker called for Congress, which has generally shown much greater urgency in dealing with the AIDS crisis, to pass legislation to compel the administration to buy generic FDCs. http://www.commondreams.org/headlines04/0518-04.htm PEPFAR is aimed at tying poor countries into using drugs produced in the US in perpetuity, although it is not in their bets interest. Bush is serving American business intererests, not those of the poor. While it would be nice to think that the leader of the free world really is a wonderful human being, I'd strongly urge you to read the text of these articles and maybe view what Bush's press machine puts out there - as he prepares to leave office - with a dose of cynicism.
< Message edited by RealityLicks -- 2/17/2008 1:01:30 AM >
|